BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29634103)

  • 1. HPLC-UV ASSAY OF IMATINIB IN HUMAN PLASMA OPTIMIZED FOR BIOEQUIVALENCE STUDIES.
    Kaza M; Piorkowska E; Filist M; Rudzki PJ
    Acta Pol Pharm; 2016 Nov; 73(6):1495-1503. PubMed ID: 29634103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.
    Rezende VM; Rivellis A; Novaes MM; de Alencar Fisher Chamone D; Bendit I
    Drug Des Devel Ther; 2013; 7():699-710. PubMed ID: 23946646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.
    Golabchifar AA; Rezaee S; Dinan NM; Kebriaeezadeh A; Rouini MR
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):527-39. PubMed ID: 26189007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantification of imatinib and its main metabolite N-demethyl-imatinib in human plasma by liquid chromatography-tandem mass spectrometry and its application to therapeutic drug monitoring in patients with gastrointestinal stromal tumor.
    Zhuang W; Qiu HB; Chen XM; Yuan XH; Yang LF; Sun XW; Zhou XJ; Huang M; Wang XD; Zhou ZW
    Biomed Chromatogr; 2017 Dec; 31(12):. PubMed ID: 28621487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
    Tan KL; Ankathil R; Gan SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3583-91. PubMed ID: 22000961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma.
    D'Aronco S; Dall'Armi M; Crotti S; Calandra E; Traldi P; Di Marco V; Buonadonna A; Corona G; Giodini L; Marangon E; Posocco B; Toffoli G; Agostini M
    J Mass Spectrom; 2017 May; 52(5):283-289. PubMed ID: 28251731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Label-Free Quantification of Anticancer Drug Imatinib in Human Plasma with Surface Enhanced Raman Spectroscopy.
    Fornasaro S; Bonifacio A; Marangon E; Buzzo M; Toffoli G; Rindzevicius T; Schmidt MS; Sergo V
    Anal Chem; 2018 Nov; 90(21):12670-12677. PubMed ID: 30350602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of imatinib targeted delivery in human leukocytes.
    Kralj E; Žakelj S; Trontelj J; Pajič T; Preložnik Zupan I; Černelč P; Ostanek B; Marc J; Kristl A
    Eur J Pharm Sci; 2013 Sep; 50(1):123-9. PubMed ID: 23643738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine.
    Kaza M; Gilant E; Filist M; Szlaska I; Pawiński T; Rudzki PJ
    Clin Biochem; 2014 Sep; 47(13-14):1313-5. PubMed ID: 24886771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection.
    Widmer N; Béguin A; Rochat B; Buclin T; Kovacsovics T; Duchosal MA; Leyvraz S; Rosselet A; Biollaz J; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):285-92. PubMed ID: 15063337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemia.
    Capron A; Antunes MV; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra M; Fogliatto L; Wallemacq P; Linden R
    Clin Chim Acta; 2016 Jan; 453():42-7. PubMed ID: 26657979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
    Zhang M; Moore GA; Fernyhough LJ; Barclay ML; Begg EJ
    Anal Bioanal Chem; 2012 Oct; 404(6-7):2091-6. PubMed ID: 22865010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application.
    Antunes MV; Raymundo S; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra MZ; Fogliatto L; Linden R
    Bioanalysis; 2015; 7(16):2105-17. PubMed ID: 26327189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards point of care systems for the therapeutic drug monitoring of imatinib.
    Pearce CM; Resmini M
    Anal Bioanal Chem; 2020 Sep; 412(24):5925-5933. PubMed ID: 32166445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field-assisted paper spray mass spectrometry for the quantitative evaluation of imatinib levels in plasma.
    D'Aronco S; Calandra E; Crotti S; Toffoli G; Marangon E; Posocco B; Traldi P; Agostini M
    Eur J Mass Spectrom (Chichester); 2016; 22(5):217-228. PubMed ID: 27882887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations.
    Schleyer E; Pursche S; Köhne CH; Schuler U; Renner U; Gschaidmeier H; Freiberg-Richter J; Leopold T; Jenke A; Bonin M; Bergemann T; le Coutre P; Gruner M; Bornhäuser M; Ottmann OG; Ehninger G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):23-36. PubMed ID: 14659433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
    Moreno JM; Wojnicz A; Steegman JL; Cano-Abad MF; Ruiz-Nuño A
    Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an high performance liquid chromatography-tandem mass spectrometry method for the determination of imatinib in rat tissues.
    Bianchi F; Caffarri E; Cavalli S; Lagrasta C; Musci M; Quaini F; Savi M
    J Pharm Biomed Anal; 2013 Jan; 73():103-7. PubMed ID: 22709608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study.
    Kim SS; Im HT; Kang IM; Lee HS; Lee HW; Cho SH; Kim JB; Lee KT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):174-9. PubMed ID: 17275423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.